Clinical Trial Update: Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Safety-focused update on cetuximab combined with oxaliplatin/5-FU/folinic acid/irinotecan as first-line therapy for metastatic colorectal cancer in Phase 1 and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-FU/FA (5-fluorouracil/folinic acid)
• Cetuximab (cetuximab)
• Irinotecan (Irinotecan)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED